iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
Key Highlights
- ➤iMDx appoints Donnie Purto as Senior Vice President of Sales
- ➤GraftAssureDx awaits FDA authorization before planned commercial launch
- ➤Purto brings over 20 years of diagnostics, life sciences and healthcare sales experience
- ➤iMDx targets disrupting transplanted organ health testing in 2027
Expert Statements
Josh Riggs, CEO of Insight Molecular Diagnostics
“We are excited to have Donnie take the reins of our commercial organization as we prepare to advance our goal of disrupting transplanted organ health testing in 2027”
Josh Riggs, CEO of Insight Molecular Diagnostics
“His ability to drive sales of products, which are based on innovative science, into positions of market leadership is exactly what we need in this next phase as we ready for a product launch. He has already established a track record in the transplant community, and we look forward to benefiting from his expertise.”
Donnie Purto, Senior Vice President of Sales at Insight Molecular Diagnostics
“I'm excited to join iMDx at such a pivotal moment for the company. Our commercial team has already built strong relationships with many of the highest volume kidney transplant centers in the country, including Cleveland Clinic, Tampa General Hospital, Mayo Clinic, Vanderbilt University and others, which were involved in the FDA submission for GraftAssureDx. That foundation gives us a head start as we prepare for a commercial launch pending FDA authorization.”
NASHVILLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced the appointment of Donnie Purto as Senior Vice President of Sales to lead the company’s commercialization efforts as it prepares to bring GraftAssureDx to market. GraftAssureDx is currently under FDA medical device review and is awaiting regulatory authorization.
Mr. Purto is an accomplished sales leader with more than 20 years of experience building and leading high-performing sales organizations across diagnostics, life sciences and healthcare. During a decade at Natera, Inc., he had success in leadership roles spanning sales, training, oncology, transplant and women’s health. Responsibilities included new product launches as well as managing hundreds of millions of dollars in revenue in highly competitive markets.
Get started
Create a free account to read the full story.